Tscan Therapeutics Correlations

TCRX Stock

USD 4.26 0.32 8.12%

The current 90-days correlation between Tscan Therapeutics and VectivBio Holding AG is 0.14 (i.e., Average diversification). The correlation of Tscan Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Tscan Therapeutics Correlation With Market

Very weak diversification

The correlation between Tscan Therapeutics and DJI is 0.48 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tscan Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Tscan Stock please use our How to Invest in Tscan Therapeutics guide.

Moving together with Tscan Stock

0.62	ME	23Andme Holding	Pair Corr
0.62	VALN	Valneva SE ADR	Pair Corr
0.61	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.64	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.63	IPSC	Century Therapeutics	Pair Corr
0.69	NKTX	Nkarta Inc	Pair Corr
0.64	TPST	Tempest Therapeutics	Pair Corr
0.62	AGL	agilon health Buyout Trend	Pair Corr
0.63	CYRX	Cryoport	Pair Corr

Moving against Tscan Stock

0.61	T	ATT Inc Aggressive Push	Pair Corr
0.6	CVX	Chevron Corp Fiscal Year End 7th of February 2025	Pair Corr
0.58	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr
0.54	BAC	Bank of America Fiscal Year End 10th of January 2025	Pair Corr
0.49	HPQ	HP Inc	Pair Corr
0.48	JPM	JPMorgan Chase Fiscal Year End 10th of January 2025	Pair Corr
0.45	INTC	Intel Fiscal Year End 23rd of January 2025	Pair Corr
0.44	HD	Home Depot	Pair Corr
0.43	VFS	VinFast Auto Earnings Call Tomorrow	Pair Corr
0.38	CAT	Caterpillar Fiscal Year End 3rd of February 2025	Pair Corr

Related Correlations Analysis

	VECT	ICVX	APLS	ITOS	DAWN	ABOS	XFOR	INZY	CGTX	TFFP
VECT		0.76	-0.82	-0.83	0.39	0.24	-0.81	-0.63	-0.59	-0.31	VECT
ICVX	0.76		-0.91	-0.91	0.27	-0.01	-0.59	-0.35	-0.81	-0.14	ICVX
APLS	-0.82	-0.91		0.94	-0.2	-0.03	0.71	0.47	0.81	0.25	APLS
ITOS	-0.83	-0.91	0.94		-0.23	0.0	0.72	0.55	0.8	0.34	ITOS
DAWN	0.39	0.27	-0.2	-0.23		0.66	0.05	-0.04	-0.02	0.28	DAWN
ABOS	0.24	-0.01	-0.03	0.0	0.66		0.1	-0.06	0.33	0.29	ABOS
XFOR	-0.81	-0.59	0.71	0.72	0.05	0.1		0.76	0.55	0.59	XFOR
INZY	-0.63	-0.35	0.47	0.55	-0.04	-0.06	0.76		0.36	0.82	INZY
CGTX	-0.59	-0.81	0.81	0.8	-0.02	0.33	0.55	0.36		0.36	CGTX
TFFP	-0.31	-0.14	0.25	0.34	0.28	0.29	0.59	0.82	0.36		TFFP
	VECT	ICVX	APLS	ITOS	DAWN	ABOS	XFOR	INZY	CGTX	TFFP

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ITOS	+ 0.94	APLS
TFFP	+ 0.82	INZY
CGTX	+ 0.81	APLS
CGTX	+ 0.8	ITOS
ICVX	+ 0.76	VECT
INZY	+ 0.76	XFOR

High negative correlations

ITOS	- 0.91	ICVX
APLS	- 0.91	ICVX
ITOS	- 0.83	VECT
APLS	- 0.82	VECT
CGTX	- 0.81	ICVX
XFOR	- 0.81	VECT

Risk-Adjusted Indicators

There is a big difference between Tscan Stock performing well and Tscan Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tscan Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
VECT	2.63	1.07	0.54	3.09	0.88	(3.64)	5.61	(3.08)	39.30
ICVX	4.87	0.96	0.17	2.53	4.56	(5.67)	10.22	(6.79)	38.57
APLS	2.39	(0.40)	0.00	(0.45)	0.00	0.00	4.31	(5.17)	15.97
ITOS	2.68	(1.19)	0.00	(0.72)	0.00	0.00	4.26	(4.52)	33.24
DAWN	2.10	(0.08)	(0.03)	0.03	2.72	(2.01)	3.84	(3.69)	11.44
ABOS	3.55	(0.52)	0.00	(0.05)	0.00	0.00	7.52	(6.67)	28.07
XFOR	4.97	(0.84)	0.00	(0.45)	0.00	0.00	6.90	(10.61)	62.35
INZY	2.74	(1.09)	0.00	(0.42)	0.00	0.00	5.68	(7.92)	16.62
CGTX	4.29	(0.86)	0.00	(0.46)	0.00	0.00	8.89	(10.34)	36.32
TFFP	6.98	(1.91)	0.00	(1.79)	0.00	0.00	11.28	(14.29)	95.77

Tscan Therapeutics Corporate Management

Justin McCue	Chief Officer	Profile
Leiden MBA	Principal Treasurer	Profile
Ray Lockard	VP Quality	Profile
Ray MBA	Senior Quality	Profile
Jim Murray	Senior Operations	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC